Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;39(Suppl 1):47-58.
doi: 10.1007/s10072-018-3337-y.

A new era in headache treatment

Michail Vikelis  1   2 , Konstantinos C Spingos  3 , Alan M Rapoport  4
Affiliations
Review

A new era in headache treatment

Michail Vikelis et al. Neurol Sci. 2018 Jun.

Abstract

Primary headache disorders, such as migraine and cluster headache, are common and often debilitating. When preventive therapy is needed, several oral medications are used. Patients tend to have poor adherence and persistence on their preventive therapy. The introduction of treatments blocking calcitonin gene-related peptide (CGRP) is anticipated to begin a new era in migraine preventive treatment. In addition, non-triptan serotonin receptor agonists, newer delivery systems for older therapies, and innovative devices represent other exciting advances in acute and preventive migraine and cluster treatment and shall also be discussed in this review.

Keywords: Calcitonin gene-related peptide (CGRP); Headache devices; Headache treatment; Magnetic stimulation; Monoclonal antibodies; Neuromodulation; Neurostimulation.

PubMed Disclaimer

References

    1. J Headache Pain. 2017 Dec;18(1):22 - PubMed
    1. N Engl J Med. 2004 Mar 11;350(11):1104-10 - PubMed
    1. Lancet Neurol. 2017 Jun;16(6):425-434 - PubMed
    1. Cephalalgia. 2008 Mar;28(3):285-95 - PubMed
    1. Neurology. 2008 Apr 15;70(16):1304-12 - PubMed

LinkOut - more resources